SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Tempest Therapeutics, Inc.
@TPST_InsiderForm 4 Filing: Yee John D. Acquires (Grant) shares of $TPST
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Tempest Therapeutics, Inc.
Ticker: $TPST
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-04
Shares: 25,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Yee John D., holds the title of Director at Tempest Therapeutics, Inc..
On 2026-06-04, the insider transacted 25,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Yee John D. (Director) was granted $0 of $TPST
Post-Transaction Position: 25,000 shares
SEC Accession No: 0001193125-26-274545 (CIK: 1926290)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.